𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Sublingual immunotherapy is safe in children, but the challenge is how to increase its efficiency?

✍ Scribed by A. Blanco Quirós; E. Arranz Sanz

Book ID
116203717
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
127 KB
Volume
39
Category
Article
ISSN
0301-0546

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

229: Twice-Daily Intravenous (IV) Busulf
229: Twice-Daily Intravenous (IV) Busulfan (Bu) x 4 Days in Children Undergoing a Reduced-Intensity Conditioning (RIC) Regimen with Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT) is Safe and Well-Tolerated but Results in Significantly Increased Bu Clearance (CL) and Decreased Area Under the Curve (AUC) and Half-Life (t1/2) When Compared to IV Bu Twice-Daily Dosing Pharmacokinetics (PK) in Adults
✍ I. Waxman; M. Bhatia; M. Milone; L.M. Shaw; L. Baldinger; O. Militano; J. Garvin 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 60 KB